drugset / Trial / NCT04045821

Endometrial Rejuvenation Study

NCT04045821

RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate the response of the endometrial lining after subcutaneous administration of the medication AMD3100. This medication mobilizes stem cells and will be used in a population of infertile women with a thin endometrium who are undergoing frozen-thawed embryo transfer. The investigators will assess associations between response to stem cell mobilization and pregnancy outcomes.

Timeline

Start
2020-01-17
Primary completion
2021-01-27
Completion
2021-05-04

Drugs

EvaluationDrugModalityDoseRoute
Subject AMD3100 Small molecule 0.24 mg/kg Subcutaneous